1. Home
  2. LQDA vs VFC Comparison

LQDA vs VFC Comparison

Compare LQDA & VFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

SELL

Current Price

$34.32

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo V.F. Corporation

VFC

V.F. Corporation

SELL

Current Price

$16.84

Market Cap

5.0B

ML Signal

SELL

Company Overview

Basic Information
Metric
LQDA
VFC
Founded
2004
1899
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.0B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
LQDA
VFC
Price
$34.32
$16.84
Analyst Decision
Buy
Buy
Analyst Count
8
24
Target Price
★ $54.38
$18.92
AVG Volume (30 Days)
4.6M
★ 10.2M
Earning Date
11-02-2026
10-28-2026
Dividend Yield
N/A
★ 2.14%
EPS Growth
51.81
★ 233.33
EPS
★ 1.26
0.64
Revenue
$158,320,000.00
★ $10,488,556,000.00
Revenue This Year
$357.27
N/A
Revenue Next Year
$1.34
$3.10
P/E Ratio
$27.38
★ $26.34
Revenue Growth
★ 1031.18
N/A
52 Week Low
$21.97
$12.46
52 Week High
$93.61
$22.27

Technical Indicators

Market Signals
Indicator
LQDA
VFC
Relative Strength Index (RSI) 34.77 77.87
Support Level $32.63 $15.81
Resistance Level $42.62 $18.01
Average True Range (ATR) 2.90 0.60
MACD 0.11 0.31
Stochastic Oscillator 23.72 85.34

Price Performance

Historical Comparison
LQDA
VFC

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About VFC V.F. Corporation

VF designs, produces, and distributes apparel, footwear, and accessories with a focus on active and outdoor brands. Its portfolio of 10 labels includes Vans, The North Face, Timberland, and Altra. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and company-owned and partner-owned branded stores. Tracing its roots to 1899, VF has evolved into its present form through many brand acquisitions and divestitures.

Share on Social Networks: